POU3F2 and cutaneous melanoma: To evaluate the prevalence of BRN2 loss in human skin cutaneous melanoma (SKCM), we retrieved copy-number alteration (CNA) data for BRN2 in SKCM metastases (stage IV) from the Cancer Genome Atlas (TCGA, https://cancergenome.nih.gov/).